GlucoTrack (NASDAQ:GCTK) Upgraded to “Sell” at Wall Street Zen

GlucoTrack (NASDAQ:GCTK) was upgraded by Wall Street Zen to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research report on Tuesday, April 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, GlucoTrack currently has an average rating of “Sell”.

GlucoTrack Stock Up 1.5%

NASDAQ:GCTK opened at $0.66 on Friday. The firm has a market capitalization of $4.13 million, a price-to-earnings ratio of -0.04 and a beta of 0.78. GlucoTrack has a twelve month low of $0.43 and a twelve month high of $15.90. The stock’s 50 day moving average price is $0.76 and its two-hundred day moving average price is $2.57. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.08.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Ikarian Capital LLC bought a new position in shares of GlucoTrack during the 4th quarter worth approximately $177,000. Boothbay Fund Management LLC bought a new position in shares of GlucoTrack during the 4th quarter worth approximately $52,000. Finally, Bank of America Corp DE boosted its stake in shares of GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after acquiring an additional 4,085 shares during the period. 10.92% of the stock is currently owned by institutional investors.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.